Agilent Technologies

NYSE: A
New York Stock Exchange
Healthcare Diagnostics & Research
Global Rank
#644
Country Rank
#286
Market Cap
33.7 B
Price
118.62
Change (%)
0.83%
Volume
1.69 M

Agilent Technologies's latest marketcap:

33.7 B

As of 06/26/2025, Agilent Technologies's market capitalization has reached $33.7 B. According to our data, Agilent Technologies is the 644th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 33.7 B
Revenue (ttm) 6.63 B
Net Income (ttm) 1.17 B
Shares Out 284.06 M
EPS (ttm) 4.06
Forward PE 20.39
Ex-Dividend Date 07/01/2025
Earnings Date 08/20/2025
Market Cap Chart
Data Updated: 06/26/2025

Agilent Technologies's yearly market capitalization.

Agilent Technologies has seen its market value drop from $34.4 B to $33.7 B since 1999, representing a total decrease of 2.06% and an annual compound decline rate (CAGR) of 0.08%.
Date Market Cap Change (%) Global Rank
06/26/2025 $33.7 B -14.02% 644
12/31/2024 $38.37 B -5.82% 518
12/29/2023 $40.74 B -8.06% 439
12/30/2022 $44.31 B -8.1% 350
12/31/2021 $48.21 B 32.61% 397
12/31/2020 $36.36 B 37.4% 467
12/31/2019 $26.46 B 23.15% 539
12/31/2018 $21.49 B -0.67% 533
12/29/2017 $21.63 B 47.57% 605
12/30/2016 $14.66 B 5.55% 712

Company Profile

About Agilent Technologies, Inc.

Agilent Technologies, Inc. delivers application-focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. Founded in 1999 and headquartered in Santa Clara, California, the company serves its customers through direct sales, distributors, resellers, manufacturer's representatives, and e-commerce.

Business Segments

  • Life Sciences and Applied Markets

    This segment offers a comprehensive portfolio of analytical instruments and solutions, including:

    • Liquid and gas chromatography systems with mass spectrometry capabilities
    • Spectroscopy instruments (ICP-MS, AA, MP-AES, ICP-OES, Raman)
    • Laboratory software, automation systems, and information management tools
    • Consumables such as GC/LC columns, sample preparation products, and custom chemistries
  • Diagnostics and Genomics

    This segment provides solutions for:

    • Genomics research and biomolecular analysis
    • Pathology and companion diagnostics
    • Cell analysis through plate-based assays, flow cytometers, and imaging systems
    • Contract manufacturing and R&D services
  • Agilent CrossLab

    This segment delivers comprehensive services including:

    • Instrument maintenance, repairs, and installations
    • Training, compliance support, and consulting
    • Software as a Service (SaaS) and asset management solutions

Frequently Asked Questions

  • What is Agilent Technologies's (A) current market cap?
    As of 06/26/2025, Agilent Technologies (including the parent company, if applicable) has an estimated market capitalization of $33.7 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Agilent Technologies global market capitalization ranking is approximately 644 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.